The 3D printing medical devices market is projected to reach USD 6.9 Billion in 2028 from USD 2.7 billion in 2022 with a CAGR of 17.1% during the forecast period. Due to Technological advancements, the cost-effectiveness of 3D printing devices, the availability of customization, and the capability of these valuable products used in industries such as healthcare, where patient-specific medical devices and prosthetics can be manufactured with precision and Sustainability, and waste reduction the market is witnessing the highest growth.
The 3D printing medical devices market is competitive, with both established companies and upcoming competitors for the same market share. As of 2021, the key players operating in the 3D Printing medical devices market are Stratasys Ltd. (Israel), EnvisionTEC (US), 3D Systems, Inc. (US), EOS (US), Renishaw plc (UK), Materialise (Belgium), 3T Additive Manufacturing Ltd. (US), GENERAL ELECTRIC COMPANY (US), Carbon, Inc. (US), Prodways Group (France)among others. Market players are moving toward offering more comprehensive solutions to end-user organizations through strategic agreements, partnerships and acquisitions. The 3D Printing devices market is well-established in North America and Europe. The focus of market players on emerging markets in the Asia Pacific is increasing and many start-up companies are gaining weight in the Asia Pacific region.
To know about the assumptions considered for the study download the pdf brochure
Stratasys Ltd. was founded in 1989 and is headquartered in Eden Prairie, Minnesota, USA. The company has a strong presence in the 3D printing industry and offers a wide range of additive manufacturing solutions, including 3D printers, materials, software, and services. Stratasys serves various industries, including aerospace, automotive, consumer goods, education, healthcare, and more. Its products include 3D printing systems, consumable materials, and software. The company’s printing systems include PolyJet printers, FDM printers, and stereolithography printers. Stratasys continues to invest in research and development to expand its capabilities and offerings in the medical field. They collaborate with hospitals, universities, and other partners to advance the use of 3D printing in healthcare and drive innovation in medical device manufacturing.
Geographically, the company operates in North America, Europe, the Asia Pacific, Latin America, and the Middle East. It distributes products and services across the US, Canada, China, Germany, Japan, Italy, Brazil, India, and South Korea, among other countries, through a network of ~200 agents and resellers across the globe. Some of its major subsidiaries are MakerBot Industries, LLC (US), Stratasys Solutions Ltd. (UK), Stratasys Schweiz AG (Switzerland), Stratasys GmbH (Germany), Stratasys Japan Co. Ltd., and Stratasys Shanghai Ltd. (China).
3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina, USA. The company is one of the pioneers in the field of 3D printing and offers a broad portfolio of 3D printers, materials, software, and services. 3D Systems serves a wide range of industries, including aerospace, automotive, consumer goods, healthcare, and more. 3D Systems has been involved in the development of 3D-printed prosthetics and orthotics. Through the use of additive manufacturing, the company aims to create personalized, comfortable, and affordable solutions for individuals in need of assistive devices.3D Systems is a global provider of a wide range of 3D printing solutions, including 3D printers, materials, software, on-demand manufacturing services, and digital design tools. The company’s extensive range of product offerings supports advanced applications in a wide array of industries, including healthcare, automotive, aerospace, and consumer goods. The company, through its precision healthcare services, provides surgical planning, modeling, prototyping, and manufacturing services. The company’s major segments include services and products.
3D Systems uses various 3D printing technologies—stereolithography (SLA), selective laser sintering (SLS), film-transfer imaging (FTI), ColorJet Printing (CJP), multi-jet printing (MJP), direct metal printing (DMP), and plastic-jet printing (PJP). Accura, DuraForm, LaserForm, CastForm, LaserForm, and VisiJet are a few of the notable 3D printing material brands of 3D Systems. The company also offers 3D virtual reality simulators and simulator modules for medical applications. The service portfolio of the company comprises warranty, maintenance, and training services; on-demand solutions; software services, including software licensing, maintenance, and others; and healthcare services. Its healthcare solutions include training & planning, simulation, printing of surgical instruments, printing for patient-specific medical & dental devices, and personalized surgery.The company manufactures and assembles various 3D printers at its facilities located in the US, Israel, and France. It also outsources certain printer production, assembly, and refurbishment activities to selected companies and suppliers. It produces print materials at its facilities and also procures from third parties, which blend to its specifications. With the growing technological changes in the 3D printing industry, the company has been focusing on ongoing R&D programs to develop new printers and printing materials as well as improve and expand the capabilities of printers, materials, and software. The company protects its technology platforms and materials as proprietary through patents, copyrights, trademarks, and trade secrets. As of December 2020, 3D Systems has 1,269 patents and 312 pending patent applications worldwide.The company, through its subsidiaries, operates in the Americas, APAC, Europe, and the Middle East. Some of its subsidiaries are 3D Canada Company, 3D Holdings, LLC (US), 3D Systems S.A. (Switzerland), 3D European Holdings Ltd. (UK), 3D Systems Asia-Pacific Pty Ltd. (Australia), 3D Systems France SARL, 3D Systems Software GmbH (Germany), and 3D Systems India, Inc
Desktop Metal, Inc. was founded in 2015 and is headquartered in Burlington, Massachusetts, USA. The company focuses on developing and commercializing metal 3D printing systems, offering a range of innovative solutions for various industries. Desktop Metal aims to make metal 3D printing more accessible and cost-effective through its proprietary technologies. Desktop Metal, Inc. is a company specializing in additive manufacturing solutions, including 3D printing technologies. Desktop Metal has been actively engaged in obtaining regulatory clearances and certifications for its 3D printing systems and materials in various markets. This includes conforming to industry standards and meeting the regulatory requirements specific to medical devices.
The company primarily focuses on selective light modulation to produce rapid prototyping systems. Its machines print in 70 proprietary photopolymers, biological materials, woven fiber composites, and sand. Several of its materials are approved for medical use. In the dental industry, EnvisionTEC’s 3D printers are used for CAD-based dental restorations, for which it offers a broad portfolio of dental and orthodontic applications. The company also offers dental materials for 3D printing, such as 3D printing resins, ABS (acrylonitrile butadiene styrene)-like materials and other biocompatible and transparent materials.
Desktop Metal, Inc. holds over 34 US and 25 foreign patents and has 143 pending patent applications. The company has a strong presence in the Americas, EMEA, and APAC. EnvisionTEC has sales, service, and training centers in the US and the UK, and its manufacturing facilities are located in Germany and the US.
Materialise is a provider of AM software solutions and complex 3D plastic printing services for industries such as healthcare, industrial manufacturing, aerospace, automotive, art and architecture, and consumer goods. The company operates through 3 business segments—Materialise Manufacturing, Materialise Medical, and Materialise Software. It employs technologies such as SLS, SLA, FDM, multi-jet modeling, and vacuum casting. Materialise serves customers from the aerospace and aeronautics, automotive, architecture, art and fashion, consumer goods, eyewear, healthcare, service bureaus, and contract manufacturing industries.
Through the Medical business segment, Materialise provides custom implants for facial parts, 3D visualization, and orthopedic and craniomaxillofacial surgical solutions. Through this segment, the company further provides clinical services and medical software to research institutes, hospitals, and major medical device manufacturing companies. With the Software segment, the company provides proprietary software packages compatible with 3D printers offered by leading OEMs such as 3D Systems (US), Arcam (Sweden), Concept Laser (Germany), EnvisionTEC (Germany), EOS GmbH (Germany), HP (US), ExOne (US), Renishaw (UK), SLM Solutions (Germany), and Stratasys (US). Magic, Streamics, 3-Matic STL, MiniMagics, Build Processors, and 3D Print Cloud, among others, are several proprietary 3D printing software offerings of the company. Through the Software segment, the company also provides software-based applications and related technologies, including CAD packages and 3D scanners. The company has patented mammoth stereolithography-based offerings, which enables it to manufacture stereolithographic models having physical dimensions of more than 2 meters. The company operates through 2 types of service centers. Customers can get their required design customized at the first center, while they get the designs that are already uploaded and ready to be used at the other center. Its offices in France, the Czech Republic, Germany, Poland, Japan, China, and South Korea, along with the significant presence of service providers in the Americas, provide global coverage to its business.
Renishaw is a scientific technology and engineering company specializing in precision management and healthcare. It has a wide range of products and services, ranging from wind turbine manufacturing and jet engines to brain surgery and dentistry. Renishaw is involved in 3D printing and operates mainly in the UK, where it designs and manufactures industrial machines that utilize metal powders for printing 3D parts. The company’s products are used in a wide range of industries, such as agriculture, automotive, aerospace, construction, power generation, medical, and consumer products. Renishaw primarily operates through two reportable business segments, namely, Manufacturing technologies and Analytical instruments and medical devices. Through its Manufacturing technologies segment, the company provides products for neurosurgery, dentistry, chemical analysis, and nanotechnology research. Renishaw offers software, scanners, frameworks, and 3D printing solutions for the dental and medical market and fully controls its dental and medical manufacturing process.
The company operates globally in 79 locations in 37 countries. Renishaw majorly manufactures its products in the UK, Ireland, Germany, France, and the US. Its major subsidiaries include Renishaw International Limited (UK), Renishaw (Canada) Limited, Renishaw AG (Switzerland), Renishaw GmbH (Germany), Renishaw (Austria) GmbH, Renishaw (Israel) Limited, Renishaw KK (Japan), and Renishaw Healthcare, Inc. (US).
3D Printing Medical Devices Market by Component (3D Printer, 3D Bioprinter, Material, Software, Service), Technology (EBM, DMLS, SLS, SLA, DLP, Polyjet), Application (Surgical Guides, Prosthetics, Implants), End User & Region - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE